Streamlining ModMed Prior Authorization for Pulmonology Practices

Klivira streamlines ModMed prior authorization for pulmonology practices, automating the complex workflows associated with high-cost biologics and essential respiratory therapies.

Revenue cycle directors and prior authorization coordinators in pulmonology face significant administrative burdens due to the volume and complexity of prior authorizations. Integrating an intelligent automation platform with ModMed's specialty-first EMR can dramatically improve efficiency, reduce denial rates, and accelerate patient access to critical treatments.

ModMed's Specialty-First EMR Approach for Pulmonology Workflows

ModMed's EMR platform is designed with a specialty-first approach, offering tailored workflows and clinical content. While ModMed primarily serves specialties like dermatology, ophthalmology, orthopedics, gastroenterology, and plastic surgery, its architecture supports adaptation for other specialties such as pulmonology. This design allows for the configuration of clinical documentation, order sets, and patient chart views to align with specific pulmonology needs, from managing severe asthma and COPD to idiopathic pulmonary fibrosis (IPF).

Addressing High-Volume Pulmonology Prior Authorizations

Pulmonology practices frequently encounter complex prior authorizations, particularly for high-cost biologics used in severe asthma (e.g., Dupixent, Nucala, Fasenra, Tezspire). PAs are also routinely required for home oxygen, BiPAP, and specific pulmonary function testing. These authorizations often necessitate precise clinical documentation, adherence to evolving step-therapy protocols, and detailed reporting of patient history, including lab results like eosinophil counts, as per ATS, GOLD, and GINA guidelines.

Klivira's Integration with ModMed via FHIR and SMART App Launch

Klivira integrates with ModMed by leveraging its FHIR R4 read APIs and SMART App Launch capabilities. This robust integration allows Klivira to launch directly from within the ModMed clinical UI, providing context-aware automation for pulmonology prior authorizations. Utilizing US Core resources, Klivira can securely pull relevant patient data, including diagnosis codes, medication history, and critical lab results such as eosinophil counts, directly from the patient chart to intelligently pre-populate PA forms.

Automating Pulmonology-Specific PA Requirements and Guidelines

Klivira's platform is engineered with a deep understanding of pulmonology-specific guidelines, incorporating GINA, GOLD, and ATS-aware step-therapy logic into its automation workflows. For severe asthma biologics, Klivira automates the collection and verification of required eosinophil counts and prior controller therapy documentation. This targeted automation streamlines the submission process for complex cases and supports efficient re-authorization workflows, aligning with payer policies and clinical best practices.

Mitigating Common Pulmonology Prior Authorization Denials

Common denial reasons in pulmonology, such as unmet step-therapy requirements for asthma biologics or insufficient eosinophil counts, can significantly disrupt revenue cycles and delay patient care. Klivira's integration with ModMed helps proactively address these challenges by ensuring all necessary documentation is complete and compliant with payer policies before submission. This approach reduces the likelihood of denials, minimizes rework, and accelerates time-to-treatment for pulmonology patients.

Frequently asked questions

How does Klivira integrate with ModMed for pulmonology prior authorizations?

Klivira integrates with ModMed's EMR using FHIR R4 read APIs and SMART App Launch. This allows Klivira to securely access relevant patient data from the ModMed patient chart and launch contextually from within the clinical workflow, streamlining data extraction and PA form pre-population for pulmonology-specific requests.

What specific pulmonology prior authorization categories does Klivira automate?

Klivira automates high-volume prior authorization categories common in pulmonology, including asthma biologics (like Dupixent, Nucala, Fasenra, Tezspire), home oxygen, BiPAP, and certain pulmonary function testing. The platform is designed to handle the nuanced documentation and step-therapy requirements for these complex cases.

Can Klivira help with documentation requirements like eosinophil counts for asthma biologics?

Yes, Klivira automates the collection and verification of critical documentation for asthma biologics, such as eosinophil counts. By integrating with ModMed's clinical data, Klivira ensures that these specific lab results and other necessary clinical criteria are accurately captured and included in the prior authorization submission, aligning with payer and guideline requirements.

How does Klivira support step-therapy requirements within ModMed for pulmonology?

Klivira incorporates GINA, GOLD, and ATS-aware step-therapy logic directly into its automation workflows. For pulmonology PAs, especially those for asthma biologics, Klivira helps ensure that prior controller therapy at maximum dose and other step-therapy criteria are documented and met, proactively addressing common denial reasons.

What are the primary benefits for ModMed pulmonology practices using Klivira?

ModMed pulmonology practices benefit from reduced administrative burden, accelerated prior authorization turnaround times, and a decrease in denial rates. By automating data extraction, applying specialty-specific logic, and streamlining submissions, Klivira allows staff to focus on patient care rather than manual PA processes.